2023 State of Specialty Spend & Trend Report
Specialty drug management remains a top concern for health payers, including managed care organizations and employers. The 2023 State of Specialty Spend and Trend Report…
Diagnostic
SOLUTIONS
Artemetrx Diagnostic
The Artemetrx Diagnostic provides a comprehensive analysis of drug spending within the medical and pharmacy benefits to enable plans to optimize their use of medications. Our analysis of the data will provide you with unparalleled transparency and insight into the drivers of spend and trend and uncover opportunities with an integrated view of medical and pharmacy data.
savings identified in 2023
pharmacy & medical claims
integrated lives
Your Roadmap to Improved Plan Performance
Innovation within pharmaceuticals has never been greater than it is today, offering treatments that cure or dramatically improve the well-being of patients. With some specialty therapies costing thousands and sometimes millions of dollars per patient, it is critically important that plans optimize their drug therapy treatment protocols and strategies. The Artemetrx Diagnostic is a comprehensive analysis of drug spending across benefits, providing insights and recommendations based on drug management best practices. We leverage the rich insights of your integrated claims dataset to analyze the medication use and costs to identify improvement opportunities.
The Artemetrx Diagnostic includes the following:
- Top therapeutic categories driving spend and identification of lower-cost medications or sites of care
- Identification of high-cost members and providers with potential cost savings
- Best practice strategies for emerging high-cost therapies and categories
- Analysis of high-cost pipeline medications and impact to the plan based on current members and utilization
- Comprehensive roadmap of opportunities with recommendations for strategies with the highest financial value and lowest member impact